3.0

credits

Average Course Rating

An elective for upper-level public health studies students with a strong biology background that reviews the basics of immunology and cancer biology, and then delves into how treatments at the interface are sparking a paradigm shift in how we understand and treat cancer. Special interest will be taken in the public health repercussions of this change in thinking and treatment. Students apply this knowledge by analyzing topics of current and potential immunotherapies such as cancer vaccinations, adoptive cell transfer therapies, immune checkpoint inhibitors, and more. Course format will be a combination of lecture and active learning activities such as facilitated discussions, case study analysis, and role-plays of system actions. Juniors/Seniors only.